| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 98.623 | 117.268 | 110.986 | 119.262 | 115.776 | 99.903 | 115.614 | 114.488 | 112.366 | 130.929 |
| Total Income - EUR | 98.623 | 117.525 | 114.695 | 119.651 | 116.704 | 101.500 | 115.850 | 123.106 | 113.759 | 146.477 |
| Total Expenses - EUR | 91.109 | 103.262 | 96.778 | 107.206 | 115.158 | 98.664 | 113.573 | 121.398 | 100.822 | 111.337 |
| Gross Profit/Loss - EUR | 7.514 | 14.263 | 17.917 | 12.446 | 1.546 | 2.837 | 2.277 | 1.708 | 12.937 | 35.140 |
| Net Profit/Loss - EUR | 6.490 | 12.575 | 16.642 | 11.206 | 334 | 2.061 | 1.134 | 541 | 11.789 | 32.536 |
| Employees | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medlens S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.239 | 27.134 | 39.348 | 40.926 | 33.774 | 41.337 | 44.527 | 24.135 | 48.792 | 59.114 |
| Current Assets | 16.530 | 21.789 | 28.593 | 27.807 | 34.967 | 26.516 | 36.136 | 49.009 | 43.311 | 44.496 |
| Inventories | 12.311 | 13.225 | 14.035 | 14.900 | 11.475 | 11.811 | 13.354 | 13.562 | 15.218 | 10.032 |
| Receivables | 461 | 1.897 | 5.139 | 1.025 | 1.421 | 1.816 | 3.304 | 3.373 | 6.984 | 11.800 |
| Cash | 3.757 | 6.667 | 9.418 | 11.882 | 22.071 | 12.888 | 19.479 | 32.074 | 21.108 | 22.663 |
| Shareholders Funds | 25.031 | 37.352 | 53.362 | 63.588 | 62.691 | 63.563 | 63.288 | 64.025 | 75.620 | 96.807 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.928 | 12.299 | 14.820 | 5.316 | 6.186 | 4.577 | 17.622 | 10.654 | 16.675 | 6.860 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Medlens S.r.l.